MONECO Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$527K Sell
3,263
-73
-2% -$12.2K 0.03% 377
2026
Q2
$633K Buy
3,336
+101
+3% +$19K 0.04% 328
2026
Q1
$638K Buy
3,235
+148
+5% +$28.5K 0.05% 265
2025
Q4
$568K Sell
3,087
-21
-0.7% -$3.68K 0.05% 284
2025
Q3
$477K Buy
3,108
+1,428
+85% +$216K 0.04% 312
2025
Q2
$235K Sell
1,680
-45
-3% -$6.31K 0.02% 427
2025
Q1
$253K Sell
1,725
-24
-1% -$3.47K 0.03% 397
2024
Q4
$229K Buy
1,749
+343
+24% +$48K 0.02% 424
2024
Q3
$219K Buy
1,406
+110
+8% +$17.8K 0.03% 404
2024
Q2
$202K Buy
+1,296
New +$195K 0.03% 409

Other funds holding AZN

MONECO Advisors's AZN Position: Q3 2026 in Review

MONECO Advisors reduced its AstraZeneca (AZN) stake by 2.2% in Q3 2026, selling an estimated $12.2K and leaving 3,263 shares worth $527K. The position accounts for 0.03% of the portfolio, ranked #377.

MONECO Advisors first reported a position in AZN in Q2 2024 and has held it in 10 quarters since. The position peaked at $638K in Q1 2026. 1,417 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • MONECO Advisors held 3,263 shares of AstraZeneca worth $527K as of Q3 2026.
  • MONECO Advisors sold 73 AstraZeneca shares in Q3 2026, an estimated $12.2K.
  • AstraZeneca made up 0.03% of MONECO Advisors's portfolio in Q3 2026, its #377 holding.
  • MONECO Advisors first reported a position in AstraZeneca in Q2 2024 and has held it in 10 quarters since.
  • MONECO Advisors's AstraZeneca position peaked at $638K in Q1 2026.
  • 1,417 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on MONECO Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.